Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Vyera Pharmaceuticals LLC
Headquarters:
New York, NY, United States of America
Website:
http://www.vyera.com
Year Founded:
2014
Status:
Private
BioCentury
|
Jan 21, 2023
Finance
Jan. 20 Quick Takes: Moderna vets pick ADARx for new VC’s debut investment
Plus: Clinical hold lifted on Astellas gene therapy, FDA reviewers scrutinize rezafungin’s benefit and updates from Deciphera, Disc and more
Read More
BioCentury
|
Jan 15, 2022
Deals
Jan. 14 Quick Takes: Verana raises $150M for real-world data
Plus Everest signs licensing deal with Singapore’s EDDC and updates from Vir, AZ, BenevolentAI and more
Read More
BioCentury
|
Dec 8, 2021
Politics, Policy & Law
FTC settles case against Shkreli’s Vyera
Martin Shkreli isn’t included in the settlement, his trial to start this month
Read More
BioCentury
|
Sep 26, 2018
Company News
Management tracks: Merck clears path for Frazier to remain CEO
Read More
BioCentury
|
Jul 19, 2018
Politics & Policy
FDA to allow limited drug importation
Read More
BioCentury
|
Mar 10, 2018
Company News
Seven years for Shkreli
Read More
BioCentury
|
Dec 22, 2016
Politics & Policy
Senate price gouging panel doesn’t recommend price controls
Read More
Items per page:
10
1 - 7 of 7
Username
Elevio by Dixa